Boston Scientific: Raymond James cuts target price to $49 from $57
BSX•Raymond James cut its target price for Boston Scientific to $49 from $57.
Related News
Raymond James raises Kymera Therapeutics target to $144 from $140
KYMR•
Northern Trust Corporation: JPMorgan raises target price to $191.50 from $185
NTRS•
Tyler Technologies, Inc.: Baird raises target price to $490 from $435
TYL•
Janux Therapeutics, Inc.: Guggenheim assumes coverage with buy rating; target price $55
JANX•
Kymera Therapeutics target price raised to $150 from $136 by Truist Securities
KYMR•